1-3 of 3
Jingjing Han
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Highly Selective and Orally Bioavailable CK1α Molecular Glue Degrader Targets B-Cell Lymphoma Cells

Ran Kong, Shi Feng, Cong Wang, Qingbo Hao, Yu Zhang, Jingjing Han, Xiaoyu Xie, Haiyang Wang, Jan Elsner, Derek Mendy, Michael Haughey, Paul Krenitsky, Veronique Plantevin-Krenitsky, Patrick Papa, Frank Mercurio, Weilin Xie, Xiangxiang Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 956.
https://doi.org/10.1182/blood-2024-208315
Published: 2024
Journal Articles

Safety and efficacy of an anti–human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models

Miao Jiang, Fei Yang, Yizhi Jiang, Lu Cheng, Jingjing Han, Jiawei Yi, Bin Zuo, Lulu Huang, Zhenni Ma, Tianyi Li, Lijuan J. Cao, Zhisong Xia, Xia Bai, Chenjun Jia, Teddy Tat Chi Yang, Naomi L. Esmon, Changgeng Ruan, Lijun Xia, Charles T. Esmon, Yue Han, Depei Wu, Jun Xu
Journal: Blood
Blood (2023) 142 (12): 1071–1081.
https://doi.org/10.1182/blood.2023020005
Published: 2023
Includes: Supplemental data
Journal Articles

The IL-27/Wsx-1 Axis Modulates T Cell Responses and Regulates Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation

Shoubao Ma, Huanle Gong, Shuangzhu Liu, Jingjing Han, Zhinan Yin, Haiyan Liu, PhD, Depei Wu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2146.
https://doi.org/10.1182/blood.V128.22.2146.2146
Published: 2016